Vaccitech plc - American Depositary Shares (NQ:VACC)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 6, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vaccitech plc - American Depositary Shares

< Previous 1 2 3 4 Next >

Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer

November 06, 2023

From Barinthus Biotherapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 31, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 09, 2023

It's time to start off the week with a breakdown of the biggest pre-market stock movers that investors need to know about for Monday!

Via InvestorPlace

Analyst Expectations for Vaccitech's Future ↗

June 13, 2023

Via Benzinga

Vaccitech: Q1 Earnings Insights ↗

May 12, 2023

Via Benzinga

Vaccitech Earnings Perspective: Return On Capital Employed ↗

March 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 26, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 26, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 25, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023 ↗

September 25, 2023

Via Benzinga

Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise

September 26, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:VACC),(NASDAQ:BPTS),(NASDAQ:RNAZ),(NYSE:BMY) EQNX::TICKER_END

Via FinancialNewsMedia

Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023

September 13, 2023

From Vaccitech plc

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Monday ↗

September 11, 2023

Monday's session saw 175 companies set new 52-week lows.

Via Benzinga

Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments

August 10, 2023

From Vaccitech plc

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Thursday ↗

September 07, 2023

On Thursday, 283 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 04, 2023

Via Benzinga

Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B

June 21, 2023

From Vaccitech plc

Via GlobeNewswire

Arbutus Doses First Patient in Additional Treatment Arm of Phase 2a Triple Combination Clinical Trial that Includes a PD-1 Monoclonal Antibody

June 21, 2023

From Arbutus Biopharma Corporation

Via GlobeNewswire

Vaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local Therapy

June 12, 2023

From Vaccitech plc

Via GlobeNewswire

Over $4M Bet On Diversified Healthcare Trust? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying ↗

June 02, 2023

The Dow Jones closed higher by around 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile

April 17, 2023

From Vaccitech plc

Via GlobeNewswire

7 Thrilling Biotech Stocks for Aggressive Investors to Buy ↗

April 05, 2023

Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.

Via InvestorPlace

Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B

March 28, 2023

From Vaccitech plc

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 24, 2023

Via Benzinga

Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 24, 2023

Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50.

Via Benzinga

Crude Oil Down 1%; US Composite PMI Jumps In March ↗

March 24, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 80 points on Friday. The Dow traded down 0.26% to 32,021.81 while the NASDAQ fell 0.41% to 11,739.58. The S&P 500,...

Via Benzinga

Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments

March 24, 2023

From Vaccitech plc

Via GlobeNewswire

Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions

March 20, 2023

From Vaccitech plc

Via GlobeNewswire

Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 23, 2023

Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.

Via Benzinga

Vaccitech Appoints Industry Veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer

January 30, 2023

From Vaccitech plc

Via GlobeNewswire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.